Delayed hypersensitivity and local control of patients treated by radiotherapy for head and neck cancer.
Delayed hypersensitivity of sixty-three patients with head and neck cancer treated by radiotherapy was correlated with short-term tumor control. Of eighteen patients with early disease, sixteen were DNCB-reactive and all were controlled and one of the two nonreactors was controlled. Thirty-three of forty-five patients with advanced tumors were reactive and nineteen were controlled. Only two of the twelve nonreactors were controlled.
D000328:Adult; D000368:Aged; D000818:Animals; D002986:Clinical Trials as Topic; D004137:Dinitrochlorobenzene / Q000276:immunology; D005260:Female; D006258:Head and Neck Neoplasms / Q000276:immunology / Q000532:radiotherapy*; D006801:Humans; D006968:Hypersensitivity, Delayed / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D009364:Neoplasm Recurrence, Local; D011446:Prospective Studies; D011879:Radiotherapy Dosage; D012882:Skin Tests
D004137:Dinitrochlorobenzene